Tested Applications
| Positive IHC detected in | human breast cancer tissue, human skin tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | A431 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:10-1:100 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
22308-1-AP targets TGF-alpha in IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | transforming growth factor, alpha |
| Calculated Molecular Weight | 17 kDa |
| GenBank Accession Number | NM_003236 |
| Gene Symbol | TGF alpha |
| Gene ID (NCBI) | 7039 |
| RRID | AB_2879069 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P01135 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for TGF-alpha antibody 22308-1-AP | Download protocol |
| IHC protocol for TGF-alpha antibody 22308-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TGF-alpha Polyclonal antibody (catalog number 22308-1-AP) has 4 citations. These appear in Molecular Cancer, Drug Design, Development and Therapy, Journal of Cellular and Molecular Medicine, and International Journal of Experimental Pathology. The associated research fields center on oncology, specifically endometrial cancer, ovarian cancer, and endocervical adenocarcinoma, with applications including immunohistochemistry (IHC) in human samples.
| Species | Application | Title |
|---|---|---|
Mol Cancer MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α. | ||
Drug Des Devel Ther Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression. | ||
J Cell Mol Med CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA. | ||
Int J Exp Pathol Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma |









